Liang Gong

No. 30 Gaotan Yanzheng Street, 
Gaotan, CN 
Clinical Trials:Currently Recruiting for 1 Trial
No. 30 Gaotan Yanzheng Street, 
Gaotan, CN 

Overview

Liang Gong practices practicing medicine in Gaotan, China.

His clinical expertise encompasses Pleural Effusion, Parapneumonic Pleural Effusion, Lung Cancer, and Acute Respiratory Distress Syndrome (ARDS).

He is actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

No. 30 Gaotan Yanzheng Street, Gaotan, 400038, China
Other Locations
Chongqing, 400038, China
Xuzhou, China
Hangzhou, China
Tanjiagang, 400038, China
MoE Key Lab Of Artificial Intelligence, Shanghai, China
The Key Laboratory Of Carbohydrate Chemistry & Biotechnology, Wuxi, 214122, China
Jiaxing, China
Punan, China
Xushan, 315300, China
Ningbo, China
Xinqiao, 400037, China
800 Dongchuan Road, Minhang, 200240, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Enrollment Status: Recruiting
Publish Date: May 27, 2026
Intervention Type: Drug
Study Drug: Repotrectinib
Study Phase: Phase 1/Phase 2

77 Total Publications

Differentiation of arterioles and capillaries in human blood vessel organoids with decellularized splenic matrix.
Differentiation of arterioles and capillaries in human blood vessel organoids with decellularized splenic matrix.
Journal: Bioactive materials
Published: January 10, 2026

Frequently Asked Questions about Liang Gong

Is Liang Gong a top-rated expert for Pleural Effusion?

MediFind is an objective health platform that identifies experts based on real-world data. Liang Gong is classified as an Experienced expert for Pleural Effusion, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Liang Gong participate in research or clinical trials?

Yes. Liang Gong has published 77 articles and abstracts on conditions like Pleural Effusion. You can view a list of Liang Gong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gong's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile